US Broker Ratings

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Strong Buy Ratings and 41.69% Potential Upside Propel Investor Interest

Alphatec Holdings, Inc. (NASDAQ: ATEC), a key player in the healthcare sector and a prominent name in the medical devices industry, has been capturing investor attention..

Galapagos NV (GLPG) Stock Analysis: Why Investors Should Watch Despite a Challenging Outlook

Galapagos NV (NASDAQ: GLPG), a Belgian biotechnology company, stands out in the sector with its focus on developing innovative treatments in oncology and immunology. With a..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 64.56% Potential Upside for Investors

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a pivotal player in the U.S. healthcare sector, offering innovative solutions to help consumers save on prescription drug purchases...

Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostics Leader with a 10.93% Upside Potential

Veracyte, Inc. (VCYT), a significant player in the healthcare sector, is making waves with its innovative approach to diagnostics and research. Headquartered in South San Francisco,..

Immunocore Holdings plc (IMCR): Investor Outlook on a Biotech Powerhouse with Over 100% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology firm, is captivating investors’ attention with its impressive strides in the healthcare sector. Specializing in the development of..

Clover Health Investments (CLOV): An Investor Outlook with a 22% Upside Potential

Clover Health Investments, Corp (NASDAQ: CLOV) is making waves in the healthcare sector with its innovative approach to Medicare Advantage plans, focusing on leveraging technology to..

IDEAYA Biosciences (IDYA) Stock Analysis: A Biotech Gem with a Potential 34.92% Upside

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading player in the biotechnology sector, is capturing investor attention with its promising pipeline of precision medicine therapies and a..

HUTCHMED (China) Limited (HCM) Stock Analysis: A 50% Upside Awaits in the Healthcare Sector

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, stands out for its commitment to the discovery, development, and commercialization of innovative therapeutics..

Xenon Pharmaceuticals (XENE) Stock Analysis: Biotechnology Innovator with a 34% Upside Potential

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biopharmaceutical company, is capturing investor attention with a significant upside potential of 34.63%, according to the latest analyst ratings...

Liquidia Corporation (LQDA) Stock Analysis: Exploring the Impressive 1,121.70% Revenue Growth and Its Impact on Future Prospects

Liquidia Corporation (NASDAQ: LQDA) has captured investor interest with its compelling growth trajectory in the biotech sector, boasting a staggering 1,121.70% revenue growth. Operating out of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Look at Its 43.5% Revenue Growth and Analyst Ratings

Alignment Healthcare, Inc. (NASDAQ: ALHC) is gaining traction in the healthcare sector, specifically within the healthcare plans industry. Focusing on a consumer-centric healthcare platform tailored for..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking Its 301% Potential Upside for Investors

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with its impressive market dynamics, particularly the staggering potential upside of over 301%. As a biotechnology..

Arcutis Biotherapeutics, Inc. (ARQT): Investor Outlook Reveals 18% Upside Potential

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is attracting significant attention in the biotechnology sector, with its robust pipeline of dermatology-focused treatments and a promising 18.09% upside based..

MoonLake Immunotherapeutics (MLTX): Navigating the Ups and Downs of a Volatile Biotech Stock

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss-based biotechnology company, is carving a niche in the healthcare sector with its innovative approach to treating inflammatory skin and joint..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring the 563.16% ROE and Future Potential

Bausch Health Companies Inc. (NYSE: BHC) is a key player in the healthcare sector, operating within the drug manufacturers – specialty and generic industry. Headquartered in..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Potential Upside Amidst Biotechnology Challenges

Recursion Pharmaceuticals, Inc. (RXRX), a burgeoning name in the biotechnology sector, has piqued the interest of investors with its innovative approach to drug discovery, despite recent..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: 15.85% Potential Upside with Strong Buy Ratings

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has captured the attention of investors with its impressive growth potential and a robust product pipeline in the eye care sector...

SS Innovations International (SSII) Stock Analysis: Unpacking a 192.5% Revenue Surge in the Healthcare Device Sector

SS Innovations International, Inc. (SSII) is capturing attention in the healthcare sector with its remarkable 192.5% revenue growth, a standout figure in the medical devices industry...

Merus N.V. (MRUS) Stock Analysis: Healthcare Innovator with 7.78% Upside Potential

Merus N.V. (NASDAQ: MRUS), a pioneering force in the biotechnology sector, is making waves with its innovative approach to immuno-oncology. Headquartered in Utrecht, the Netherlands, this..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Expert Ratings Signal Robust 78.16% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is making waves in the biotech sector with its strong potential for growth, underscored by an impressive analyst rating. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds